Let me know when the data is updated again

DIMEFAR, S.A. DE C.V.

Summary of sales of medicines and medical supplies

755 purchase as supplier for a total of 160.8 millones (160,816,947.713 ) between 2008 and 2018.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

4.8 millones pesos mexicanos (4,777,759.78 MXN)

Overcost in %

17.9 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
VINCRISTINA 54 887,883.1 MXN 32,356.9 MXN 4.73 % 2009 - 2010
SENÓSIDOS A-B 41 32.1 millones MXN 132,336.2 MXN 10.2 % 2010 - 2012
ERITROMICINA 25 560,973.6 MXN 248,377.5 MXN 79.5 % 2009 - 2009
VANCOMICINA 25 449,682 MXN 46,087.6 MXN 9.98 % 2009 - 2011
SUCRALFATO 20 1.2 millones MXN 0 MXN 0 % 2015 - 2015
LATANOPROST 18 7.6 millones MXN 620.7 MXN 0.667 % 2009 - 2012
PIPERACILINA-TAZOBACTAM 18 457,586.2 MXN 135,693.5 MXN 45 % 2009 - 2010
AMIODARONA 16 266,918.7 MXN 1,992.9 MXN 3.8 % 2009 - 2012
LEVETIRACETAM 15 631,263.4 MXN 39,126 MXN 5.18 % 2014 - 2016

Location

Country

México

GENERAL INFORMATION

Alternative names

  • DIMEFAR S A DE C V
  • DIMEFAR S.A. DE C.V.
  • DIMEFAR S.A DE C.V
  • Dimefar S. A. de C. V.

Entity type

profit

Identifiers

RFC: DIM0701255Z9

Date updated in QQW

24 de enero de 2019

Organization responsible for the import

PODER